Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPIs for Eustachian Tube Dysfunction and LPR
NCT02123498Phase 4Withdrawn
- Sponsor
- Loma Linda University
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole, ranitidine in laryngopharyngeal reflux (LPR), Eustachian tube dysfunction (ETD), sponsored by Loma Linda University. Status: withdrawn.
02
Drugs
omeprazoleranitidine
03
Conditions
laryngopharyngeal reflux (LPR)Eustachian tube dysfunction (ETD)
Beyond the preview
Go deeper on NCT02123498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123498.